| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1007566B1 Therapeutic use of the smr1 protein and active derivatives thereof |
| 08/23/2006 | CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1822879A Use of whey permeate for the treatment of metabolic syndrome |
| 08/23/2006 | CN1820776A Process for preparing micrometer yinlanzha, konjak, sugar, fat reducing and weight reducing oral liquor |
| 08/23/2006 | CN1820775A Process for preparing micrometer yinlanzha, konjak, sugar, fat reaucing and weight reducing granule, capsule and tablet |
| 08/23/2006 | CN1820769A Process for preparing micrometer ginseng, tortoise, pearl and pollen wine for nourishing yin and removing fatigue |
| 08/23/2006 | CN1820768A Process for preparing micrometer ginseng, tortoise, pearl and pollen oral liquor for nourishing yin, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820767A Process for preparing micrometer ginseng, tortoise pearl pollen granules, capsule and tablet for nourishing yin, removing fatigue and supplementing granule calcium |
| 08/23/2006 | CN1820766A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820765A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen calcium supplement granule capsule and tablet for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820740A Oral liquor for supplementing calcium and zinc and preparing method |
| 08/23/2006 | CN1820739A Sibutramine hydrochloride chewing tablet and its preparing method |
| 08/23/2006 | CN1820642A Compound adzuki bean fat reducing medicinal food |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271200C High-biomass iron-riched yeast and breeding method thereof |
| 08/23/2006 | CN1271088C Oil soluble O-chitosan derivatives and their preparation and use |
| 08/23/2006 | CN1271086C GLP-1 derivs. |
| 08/23/2006 | CN1270733C Preparation for treating diabetes mellitus |
| 08/23/2006 | CN1270731C Composition for adjusting blood fat and preparing method thereof |
| 08/23/2006 | CN1270724C Drugs for ameliorating postcibal hyperglycaemia |
| 08/23/2006 | CN1270720C Yolk lecithin for injection and method for making same |
| 08/23/2006 | CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 08/23/2006 | CN1270697C Method of preparation oral nano nourishing emulsion |
| 08/23/2006 | CN1270634C Soft capsule of dried oviduct fat of forest frog |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094774 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/17/2006 | WO2006086727A2 Treating diabetes with glucagon-like peptide-1 secretagogues |
| 08/17/2006 | WO2006086680A1 Methods of making pravastatin sodium |
| 08/17/2006 | WO2006086539A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs |
| 08/17/2006 | WO2006086464A2 Dihydroquinazolinones as 5ht modulators |
| 08/17/2006 | WO2006086447A2 Pyridazine derivatives and their use as therapeutic agents |
| 08/17/2006 | WO2006086445A2 Combination therapy |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/17/2006 | WO2006085685A1 Pyrazole compound |
| 08/17/2006 | WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same |
| 08/17/2006 | WO2006085562A1 Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome |
| 08/17/2006 | WO2006085523A1 Composition inhibiting rise in blood glucose level |
| 08/17/2006 | WO2006085516A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | WO2006085497A1 Tablet disintegrating in the oral cavity |
| 08/17/2006 | WO2006085111A1 Anthranilic acid derivatives active at the hm74a receptor |
| 08/17/2006 | WO2006084975A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | WO2006084757A2 Combination of ca/mg salt of valsartan with an antidiabetic agent |
| 08/17/2006 | WO2006084383A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | WO2006066599A3 Mas related g protein coupled receptors as drug targets |
| 08/17/2006 | WO2006059164A3 Pyrrolopyridine-2-carboxylic acid amides |
| 08/17/2006 | WO2006052768A3 Process for preparing quinoline compounds and products obtained therefrom |
| 08/17/2006 | WO2006046135A3 Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/17/2006 | WO2006007412B1 Peptide yy formulations having increased stability and resistance to microbial agents |
| 08/17/2006 | WO2005115422A3 Compositions containing avocado leaf extract for lowering cholesterol levels |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183929 Crystals of the sodium salt of pravastatin |
| 08/17/2006 | US20060183921 Pharmaceutically active compounds and methods of use |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183774 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183755 Tyrosine kinase inhibitors |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183692 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 08/17/2006 | US20060183677 Novel exendin agonist formulations and methods of administration thereof |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183670 Autoantigen composition |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182784 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 08/17/2006 | US20060182730 Antiobesity agent using hen's egg antibody against digestive enzymes |
| 08/17/2006 | CA2639880A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | CA2597583A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | CA2597073A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/17/2006 | CA2597067A1 Use of an scd-1 inhibitor to reduce adverse weight gain arising from drug therapy |
| 08/17/2006 | CA2596613A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | CA2595635A1 Methods of making pravastatin sodium |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690863A1 Novel condensed imidazole derivative |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1690519A1 Alpha-glucosidase activity inhibitor |
| 08/16/2006 | EP1689757A1 Heterocyclic boronic acid compounds |